OssDsign (OM:OSSD) - Prezzo delle azioni, notizie e analisi

OSSD Panoramica delle azioni

OSSD analisi fondamentale
Punteggio fiocco di neve
Valutazione	3/6
Crescita futura	2/6
Prestazioni passate	0/6
Salute finanziaria	6/6
Dividendi	0/6

Premi

Si prevede che i ricavi cresceranno 24.94% all'anno

Gli analisti concordano sul fatto che il prezzo delle azioni salirà di 43.2%

Analisi del rischio

Attualmente non redditizio e non si prevede che diventerà redditizio nei prossimi 3 anni

Non ha una capitalizzazione di mercato significativa ( SEK818M )

OssDsign AB (publ) Concorrenti

Bactiguard Holding

OM:BACTI B

SEK 1.2b

Xvivo Perfusion

OM:XVIVO

SEK 14.6b

Invent Medic Sweden

NGM:IMS

SEK 32.9m

Bio-Works Technologies

NGM:BIOWKS

SEK 69.4m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per OssDsign
Prezzi storici delle azioni
Prezzo attuale dell'azione	SEK 8.38
Massimo di 52 settimane	SEK 10.94
Minimo di 52 settimane	SEK 5.91
Beta	0.84
1Variazione di 1 mese	27.36%
Variazione a 3 mesi	8.69%
Variazione di 1 anno	19.71%
3Variazione a 3 anni	3.58%
Variazione a 5 anni	-51.56%
Variazione dall'IPO	-63.57%

Notizie e aggiornamenti recenti

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 15

OssDsign AB (publ)'s (STO:OSSD) Share Price Matching Investor Opinion

Nov 13

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 23

Recent updates

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 15

OssDsign AB (publ)'s (STO:OSSD) Share Price Matching Investor Opinion

Nov 13

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 23

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Aug 06

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

Jun 19

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

Mar 19

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Aug 19

Rendimenti per gli azionisti

	OSSD	SE Medical Equipment	SE Mercato
7D	3.7%	0.8%	0.7%
1Y	19.7%	-4.3%	12.3%

Ritorno vs Industria: OSSD ha superato il Swedish Medical Equipment che ha restituito -4.3 % nell'ultimo anno.

Rendimento vs Mercato: OSSD ha superato il mercato Swedish che ha restituito 12.3 % nell'ultimo anno.

Volatilità dei prezzi

Is OSSD's price volatile compared to industry and market?
OSSD volatility
OSSD Average Weekly Movement	7.7%
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	5.5%
10% most volatile stocks in SE Market	11.4%
10% least volatile stocks in SE Market	3.3%

Prezzo delle azioni stabile: OSSD non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 8% ) di OSSD è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2011	25	Morten Henneveld	www.ossdsign.com

OssDsign AB (publ) progetta, produce e vende impianti e materiali tecnologici per la rigenerazione ossea in Svezia, Germania, Stati Uniti, Regno Unito, resto d'Europa e a livello internazionale. Offre OssDsign Catalyst, un innesto osseo nanosintetico utilizzato per stimolare la crescita ossea nelle fusioni spinali. L'azienda è stata fondata nel 2011 e ha sede a Uppsala, in Svezia.

OssDsign AB (publ) Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di OssDsign con la sua capitalizzazione di mercato?
OSSD statistiche fondamentali
Capitalizzazione di mercato	SEK 818.38m
Guadagni(TTM)	-SEK 90.44m
Ricavi(TTM)	SEK 127.49m

6.4x

Rapporto P/S

-9.0x

Rapporto P/E

OSSD è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
OSSD Conto economico (TTM)
Ricavi	SEK 127.49m
Costo del fatturato	SEK 14.48m
Profitto lordo	SEK 113.01m
Altre spese	SEK 203.45m
Guadagni	-SEK 90.44m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

Feb 04, 2025

Utile per azione (EPS)	-0.93
Margine lordo	88.64%
Margine di profitto netto	-70.94%
Rapporto debito/patrimonio netto	0.2%

Come si è comportato OSSD nel lungo periodo?

Vedi performance storica e confronto

OSSD Panoramica delle azioni

Premi

Analisi del rischio

OssDsign AB (publ) Concorrenti

OM:BACTI B

SEK 1.2b

OM:XVIVO

SEK 14.6b

NGM:IMS

SEK 32.9m

NGM:BIOWKS

SEK 69.4m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Price target decreased by 8.9% to kr12.00

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

New minor risk - Share price stability

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ)'s (STO:OSSD) Share Price Matching Investor Opinion

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Recent updates

Price target decreased by 8.9% to kr12.00

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

New minor risk - Share price stability

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ)'s (STO:OSSD) Share Price Matching Investor Opinion

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Second quarter 2024 earnings: EPS misses analyst expectations

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

OssDsign AB (publ) Approves Election of Christer Fåhraeus as Ordinary Board Member

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

OssDsign AB (publ) to Report Fiscal Year 2023 Final Results on Jun 04, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ) to Report Fiscal Year 2023 Final Results on May 22, 2024

No longer forecast to breakeven

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer

New minor risk - Share price stability

Forecast breakeven date moved forward to 2024

OssDsign AB (publ), Annual General Meeting, May 21, 2024

Consensus EPS estimates fall by 30%, revenue upgraded

Forecast breakeven date moved forward to 2024

OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion

OssDsign AB (publ) to Report Q3, 2024 Results on Nov 05, 2024

OssDsign AB (publ) Reports Exceptional Data from the Clinical Study TOP FUSION

Ossdsign AB (Publ) Provides Revenue Guidance for the Fourth Quarter of 2023

An Unknown buyer acquired 7.6% stake in OssDsign AB (publ) (OM:OSSD).

OssDsign AB (publ) to Report Fiscal Year 2023 Results on Feb 06, 2024

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 150.000003 million.

OssDsign AB (publ) Announces All Activities Pertaining to the Patient-Specific Cranial Implant Business Will Be Discontinued in A Responsible Manner by the End of December 2023

OssDsign Receives FDA Clearance for A New Major Indication

Consensus EPS estimates fall by 15%

Consensus estimates of losses per share improve by 14%

Second quarter 2023 earnings released: kr0.30 loss per share (vs kr0.40 loss in 2Q 2022)

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Forecast breakeven date moved forward to 2024

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

No longer forecast to breakeven

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Full year 2022 earnings released: kr1.70 loss per share (vs kr1.94 loss in FY 2021)

OssDsign AB (publ) to Report Fiscal Year 2022 Results on Feb 21, 2023

Forecast to breakeven in 2025

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 65.63568 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

OssDsign AB (publ) Ordinary Shares to Be Deleted from OTC Equity

High number of new directors

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

OssDsign AB (publ) Elects Jill Shiaparelli as Board Member

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to kr14.00

Insufficient new directors

Consensus revenue estimates fall by 16%

Chief Executive Officer recently bought kr133k worth of stock

Chief Executive Officer recently bought kr133k worth of stock

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ), Annual General Meeting, Jun 02, 2022